Kuros Biosciences (Switzerland) Market Value

KURN Stock  CHF 6.67  0.14  2.14%   
Kuros Biosciences' market value is the price at which a share of Kuros Biosciences trades on a public exchange. It measures the collective expectations of Kuros Biosciences AG investors about its performance. Kuros Biosciences is selling for under 6.67 as of the 5th of May 2024; that is 2.14 percent increase since the beginning of the trading day. The stock's lowest day price was 6.5.
With this module, you can estimate the performance of a buy and hold strategy of Kuros Biosciences AG and determine expected loss or profit from investing in Kuros Biosciences over a given investment horizon. Check out Kuros Biosciences Correlation, Kuros Biosciences Volatility and Kuros Biosciences Alpha and Beta module to complement your research on Kuros Biosciences.
Symbol

Please note, there is a significant difference between Kuros Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kuros Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kuros Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kuros Biosciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kuros Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kuros Biosciences.
0.00
04/05/2024
No Change 0.00  0.0 
In 31 days
05/05/2024
0.00
If you would invest  0.00  in Kuros Biosciences on April 5, 2024 and sell it all today you would earn a total of 0.00 from holding Kuros Biosciences AG or generate 0.0% return on investment in Kuros Biosciences over 30 days. Kuros Biosciences is related to or competes with Molecular Partners, and COSMO Pharmaceuticals. Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of bioph... More

Kuros Biosciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kuros Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kuros Biosciences AG upside and downside potential and time the market with a certain degree of confidence.

Kuros Biosciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kuros Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kuros Biosciences' standard deviation. In reality, there are many statistical measures that can use Kuros Biosciences historical prices to predict the future Kuros Biosciences' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kuros Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.004.39
Details
Intrinsic
Valuation
LowRealHigh
0.000.004.39
Details
Naive
Forecast
LowNextHigh
1.445.8310.23
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.286.707.13
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kuros Biosciences. Your research has to be compared to or analyzed against Kuros Biosciences' peers to derive any actionable benefits. When done correctly, Kuros Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Kuros Biosciences.

Kuros Biosciences Backtested Returns

Kuros Biosciences appears to be out of control, given 3 months investment horizon. Kuros Biosciences has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11% return per unit of risk over the last 3 months. We have found thirty technical indicators for Kuros Biosciences, which you can use to evaluate the volatility of the firm. Please exercise Kuros Biosciences' Risk Adjusted Performance of 0.0822, downside deviation of 4.26, and Mean Deviation of 3.04 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kuros Biosciences holds a performance score of 8. The company secures a Beta (Market Risk) of 0.24, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Kuros Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Kuros Biosciences is expected to be smaller as well. Please check Kuros Biosciences' treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Kuros Biosciences' current price movements will revert.

Auto-correlation

    
  -0.68  

Very good reverse predictability

Kuros Biosciences AG has very good reverse predictability. Overlapping area represents the amount of predictability between Kuros Biosciences time series from 5th of April 2024 to 20th of April 2024 and 20th of April 2024 to 5th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kuros Biosciences price movement. The serial correlation of -0.68 indicates that around 68.0% of current Kuros Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient-0.68
Spearman Rank Test-0.3
Residual Average0.0
Price Variance0.22

Kuros Biosciences lagged returns against current returns

Autocorrelation, which is Kuros Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kuros Biosciences' stock expected returns. We can calculate the autocorrelation of Kuros Biosciences returns to help us make a trade decision. For example, suppose you find that Kuros Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Kuros Biosciences regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kuros Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kuros Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kuros Biosciences stock over time.
   Current vs Lagged Prices   
       Timeline  

Kuros Biosciences Lagged Returns

When evaluating Kuros Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kuros Biosciences stock have on its future price. Kuros Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kuros Biosciences autocorrelation shows the relationship between Kuros Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Kuros Biosciences AG.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Kuros Biosciences Correlation, Kuros Biosciences Volatility and Kuros Biosciences Alpha and Beta module to complement your research on Kuros Biosciences.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Kuros Stock analysis

When running Kuros Biosciences' price analysis, check to measure Kuros Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kuros Biosciences is operating at the current time. Most of Kuros Biosciences' value examination focuses on studying past and present price action to predict the probability of Kuros Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kuros Biosciences' price. Additionally, you may evaluate how the addition of Kuros Biosciences to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Kuros Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Kuros Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kuros Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...